"By examining the effects of tissue oxygenation at the cellular level, Hydron is establishing that delivering high levels of oxygen through microbubble-laden fluids can positively affect treatments for wounds, burns and numerous other skin conditions," said Terrence McGrath, Hydron's chief operating officer.
The results published by Florida Atlantic University (FAU) are thought to be a catalyst for additional cellular-level research, establishing parameters for new products and treatments.
The first study undertaken was designed to determine cell viability when exposed to Hydron's super-oxygenated fluids. It was recorded that when skin cells were cultured in the presence or absence of oxygenated microbubbles, exposure had no toxic or negative effect on cell survival.
Researchers also carried out an investigation on levels of specialized proteins called HSPs, which are induced in cells under a wide variety of stress conditions and are important for cell survival in many clinical disorders.
In studies on wound healing, it has been found that HSPs at the site of wounds improve healing. The study showed that using oxygen-laden microbubbles increased the specialised protein levels in the skin cells.
Recognized experts on cells in low oxygen environments, Peter Lutz and Howard Prentice of FAU concluded that with both studies combined, Hydron's technology is found to encourage cell survival.
Hydron Technologies markets a broad range of personal care products and it has recently concluded a private placement financing to accelerate its research programme and development of viable products.